New Product Watch

Premium

Agilent Technologies this week launched its SureSelect Kinome Target Enrichment Kit. The kit enables researchers to focus their next-generation sequencing studies on expressed kinases, the firm said.

Agilent's new assay was developed with Rene Bernards of the Netherlands Cancer Institute and targets genes for greater than 500 known kinases plus a number of cancer genes and untranslated regions. Customers can use Agilent's eArray xD tool to design custom kits.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.